Cargando…
SMAD4 Overexpression in Patients with Sleep Apnoea May Be Associated with Cardiometabolic Comorbidities
Obstructive sleep apnoea (OSA) is associated with several diseases related to metabolic and cardiovascular risk. Although the mechanisms involved in the development of these disorders may vary, OSA patients frequently present an increase in transforming growth factor beta (TGFβ), the activity of whi...
Autores principales: | Díaz-García, Elena, Jaureguizar, Ana, Casitas, Raquel, García-Tovar, Sara, Sánchez-Sánchez, Begoña, Zamarrón, Ester, López-Collazo, Eduardo, García-Río, Francisco, Cubillos-Zapata, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464800/ https://www.ncbi.nlm.nih.gov/pubmed/32722512 http://dx.doi.org/10.3390/jcm9082378 |
Ejemplares similares
-
Intermittent Hypoxia Mediates Paraspeckle Protein-1 Upregulation in Sleep Apnea
por: Díaz-García, Elena, et al.
Publicado: (2021) -
Upregulated Proteasome Subunits in COVID-19 Patients: A Link with Hypoxemia, Lymphopenia and Inflammation
por: Alfaro, Enrique, et al.
Publicado: (2022) -
SMAD4 Expression in Monocytes as a Potential Biomarker for Atherosclerosis Risk in Patients with Obstructive Sleep Apnea
por: Díaz-García, Elena, et al.
Publicado: (2023) -
Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
por: Alfaro, Enrique, et al.
Publicado: (2022) -
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
por: van Zeller, Mafalda, et al.
Publicado: (2023)